Approval based on MIRROR randomized controlled trial, which showed significant improvement and sustained patient response to KRYSTEXXA with methotrexate compared to KRYSTEXXA alone. Trial data showed a greater than 30… Read More
VANCOUVER, BC — Life Sciences BC (LSBC) is pleased to announce the recipients of the 24th Annual Life Sciences BC Awards, presented by Farris. These awards recognize the achievements of… Read More
VANCOUVER, BC — Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a clinical stage Canadian pharmaceutical development company, is pleased to provide an update on… Read More
SBME’s Capstone Design course is looking for project proposals from industry clients with challenging design problems! Participating companies have benefitted by promoting their organization to UBC students and researchers, working… Read More
VANCOUVER, BC— Clairvoyant Therapeutics, a Canadian biotech company, is pleased to announce it has initiated the first of 15 planned sites for CLARITY, the company’s Phase 2 clinical trial investigating psilocybin… Read More
